Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: HTC 10 Million and Possible Substantive Ruling Impact
Page 39 - "115. For HTC the amount of the lump sum payment the parties would agree to based on the above royalty rate and royalty base is $10 million.167 A small portion of that amount, or $30,000, would relate to sales post-trial." <<<<>>>> "the parties"
Share
New Message
Please login to post a reply